Antibacterial drugs are important for treating infections. But increasingly, bacterial resistance to current drugs -; so they don’t work well, or even at all -; means new ones are urgently needed.
‘Too elegant to ignore’: Novo-allied Aspect Biosystems nabs $115M for bioprinted tissue therapies
A Canadian biotech creating bioprinted tissue therapeutics for type 1 diabetes, obesity and other endocrine and metabolic disorders has raised $115 million in a Series